(NASDAQ: AIRS) Airsculpt Technologies's forecast annual revenue growth rate of 1.02% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 3.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.55%.
Airsculpt Technologies's revenue in 2026 is $147,675,000.On average, 6 Wall Street analysts forecast AIRS's revenue for 2026 to be $11,031,976,532, with the lowest AIRS revenue forecast at $10,434,654,477, and the highest AIRS revenue forecast at $11,783,064,662. On average, 6 Wall Street analysts forecast AIRS's revenue for 2027 to be $11,215,313,005, with the lowest AIRS revenue forecast at $10,084,984,511, and the highest AIRS revenue forecast at $12,124,602,768.
In 2028, AIRS is forecast to generate $11,165,782,587 in revenue, with the lowest revenue forecast at $10,200,309,066 and the highest revenue forecast at $12,197,789,505.